Prenetics Global (PRE) Sidoti Micro-Cap Virtual Investor Conference summary
Event summary combining transcript, slides, and related documents.
Sidoti Micro-Cap Virtual Investor Conference summary
21 Jan, 2026Executive overview
IM8, co-founded with David Beckham, has rapidly scaled to $120 million ARR, becoming the fastest supplement brand to reach this milestone in under 12 months.
The business is now 95% focused on IM8, with divestments of other units and a strong net asset value of $560 million, including $110 million in cash and a $70 million stake in Insighta.
Projected revenues are $180–$200 million for 2026 and $350–$400 million for 2027, with 80% of customers on recurring subscriptions and a 60% gross margin.
IM8 leverages high-profile ambassadors, including Aryna Sabalenka, and advanced AI-driven marketing, achieving significant social media reach and customer engagement.
The company is well-capitalized, with no debt and a focus on global expansion, new SKUs, and further localization to drive growth.
Product innovation and differentiation
IM8 simplifies nutrition by replacing 16 supplements with a single powder, supported by a scientific advisory board and clinical trials showing high efficacy.
The product is NSF Certified for Sport, ensuring safety and transparency, and is trusted by elite athletes.
Customer experience is prioritized from formulation to post-purchase, with a focus on taste, convenience, and transparency through published third-party test results.
Over 540,000 purchases and 16 million servings delivered, with an average order value rising from $110 to over $200 due to new products and subscription models.
Global shipping to 31 countries and a direct-to-consumer model drive high retention and recurring revenue.
Financial performance and outlook
Achieved $60 million in IM8 revenue in 2025, with a forecast of $180–$200 million in 2026 and $350–$400 million in 2027.
Gross margin for IM8 is 60%, with overall company gross profit at 49% due to legacy lower-margin businesses.
Customer acquisition cost (CAC) has increased with higher average order value, but payback period has improved to under three months, outperforming industry benchmarks.
Marketing spend is 85% on Meta and 15% on Google, with plans to diversify into YouTube, TikTok, and other channels.
No need for additional capital, with losses decreasing each quarter and strong liquidity to fund growth initiatives.
Latest events from Prenetics Global
- IM8's rapid global growth and innovation set the stage for $200M revenue and profitability by 2027.PRE
Sidoti March Small-Cap Virtual Conference25 Mar 2026 - Authentic influencer partnerships and product efficacy drive sustainable brand growth.PRE
The 38th Annual Roth Conference24 Mar 2026 - IM8 achieved $100M ARR in under a year, driven by innovation, global reach, and AI-powered marketing.PRE
The 38th Annual Roth Conference23 Mar 2026 - FY2025 revenue jumped 480% to $92.4M, IM8 hit $120M ARR, and liquidity reached $171M.PRE
Q4 202518 Feb 2026 - Consumer health firm pursues $1B offering, rapid growth, and major Bitcoin treasury strategy.PRE
Registration Filing16 Dec 2025 - $1B shelf registration supports consumer health growth and a major Bitcoin treasury strategy.PRE
Registration Filing16 Dec 2025 - Consumer health innovator pursues aggressive Bitcoin treasury strategy amid rapid global growth.PRE
Registration Filing16 Dec 2025 - IM8's explosive growth and global reach drive a focused strategy with strong financials.PRE
Sidoti's Year End Virtual Investor Conference11 Dec 2025 - Q3 revenue up 568% YoY to $23.6M, with global expansion and margin gains driving growth.PRE
Q3 202517 Nov 2025